Results

Total Results: 1,546 records

Showing results for "drug".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - study enrollment Median 64 13 NR NR NR NR NR NR NR Patients with major psychiatric disorder or past drug … preparation Mean 50 23 NR NR NR NR NR Mean 48 Patients with bipolar disorder or psychosis excluded Comparison drug
  2. effectivehealthcare.ahrq.gov/health-topics/autoimmune-diseases
  3. effectivehealthcare.ahrq.gov/health-topics/acute-myeloid-leukemia
  4. effectivehealthcare.ahrq.gov/health-topics/giardia-infections
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
    April 01, 2010 - We anticipate that IV methods will be often underpowered for drug safety studies of very rare outcomes … The new drug is added to the formulary in some hospitals; however, because of cost and concerns about … Variation in formularies, hospital capacity, and prescription drug benefit plan structure can also … Pharmacoepidemiol Drug Saf 2009;18:932-940. 37. Korn EL, Baumrind S. … Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
    June 01, 2013 - Food and Drug Administration Web site, ClinicalTrials.gov, and conference abstracts (American Society
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-interventions-maltreatment-child_executive.pdf
    April 01, 2013 - Childhood victimization and illicit drug use in middle adulthood.
  8. effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-hospital-length-of-stay.pdf
    November 01, 2019 - Does the nomination represent a health care drug, intervention, device, technology, or health care
  9. CERs Report cover (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
    September 23, 2010 - As part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress directed
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
    March 01, 2012 - In one study, 0.4 percent of the included infants developed drug-related rash and 18.9 percent had
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
    May 01, 2025 - Drug-Induced Gingival Hyperplasia in Transplant Recipients.
  12. effectivehealthcare.ahrq.gov/health-topics/hivaids
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - However, clopidogrel metabolism is also influenced by drug-drug interactions such as PPIs, calcium channel … While concluding their argument, the authors ignored many important things including the role of drug-drug … We agree that drug-drug, gene-drug, or other interactions are potentially affecting the prognostic value … Ticagrelor is a direct drug although the active metabolite is as potent as native clopidogrel. … Therefore, it is important for measurement of the drug effect to be highly specific.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
    April 01, 2013 - would produce prima facie evidence that a conclusion was out of date, such as the withdrawal of a drug … Is the portion of the CER that is probably or certainly out of date an issue of safety (a drug withdrawn … from the market, a black box warning) or the availability of a new drug within class (the latter being … original key questions, the conclusions of the original report, the results of the literature and drug … aspiration thrombectomy Vink, 20125 (PASSION) Post hoc analysis of RCT Patients being randomized to drug
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
    February 01, 2010 - As part of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Congress directed … We have no data on concomitant drug treatment or on control of coronary risk factors during follow-up … None of the ten trials included in this study used drug-eluting stents for PCI. … stents,36 trials that compare CABG with PCI by use of drug-eluting stents are still in progress.33,37 … A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.
  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
    January 01, 2007 - We assessed statistically each of the 66 possible drug comparisons of second-generation antidepressants … Direct evidence from head-to-head trials was considered sufficient to conduct meta-analyses for four drug-drug … Issues We found no studies that identified reliable predictors of individual responses to a specific drug … , many patients try multiple antidepressant medications before finding an effective, well-tolerated drug … , but predicting which drug will be most effective or best tolerated in any given individual is not yet
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
    March 10, 2010 - The EPC first looks at the universe of studies of ACE inhibitors and ARBs before assessing the two drug … One cannot assume that two different classes of drug are interchangeable, thus justifying combining … providing an initial analysis with both ACE inhibitors and ARBs and then providing them with each drug … - aldosterone system (RAAS) antagonists provide benefits and there are only two RAAS antagonistic drug … The initial and target doses vary for each drug, depending on whether it is used for HTN, HF, or left
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
    November 30, 2011 - .); effects of dose and duration of therapy; and benefits and harms of different combinations of drug … Population(s):  Non-co-infected adults with HCV infection who have not had previous antiviral drug … US Food and Drug Administration. FDA approves Incivek for hepatitis C. … US Food and Drug Administration. FDA approves Victrelis for hepatitis C. … Drug Class Review on Pegylated Interferons for Hepatitis C. 2007.
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - study in 1998, Haissaguerre and colleagues studied 45 patients with paroxysmal AF (PAF) refractory to drug … comparing 8 mm tip catheters to irrigated (closed or open) tip catheters in patients undergoing PVI for drug … There is a low level of evidence suggesting no differences in rhythm control in patients with drug- refractory … patients in each trial did not show significant differences in the outcomes of PVI in patients with drug-refractory
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
    April 01, 2013 - identify relevant gray literature: (1) a request for scientific information packets submitted to drug … The drug classes in our review sometimes included drugs with diverse mechanisms of action. … When results varied by drug, we assigned separate SOE. … Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. … Pharmacoepidemiol Drug Saf. 2011;20(1):66-75. PMID: 21182154. 62.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: